Histopathology of liver biopsies from a thiopurine-naive inflammatory bowel disease cohort: Prevalence of nodular regenerative hyperplasia

被引:62
|
作者
De Boer, Nanne K. H. [1 ]
Tuynman, Henriette [2 ]
Bloemena, Elisabeth [4 ]
Westerga, Johan [3 ]
Van Der Peet, Donald L. [5 ]
Mulder, Chris J. J. [1 ]
Cuesta, Miquel A. [5 ]
Meuwissen, Stephan G. M. [1 ]
Van Nieuwkerk, Carin M. [1 ]
Van Bodegraven, Adriaan A. [1 ]
机构
[1] Vrije Univ Amsterdam, Dept Gastroenterol & Hepatol, Med Ctr, NL-1007 MB Amsterdam, Netherlands
[2] Slotervaart Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[3] Slotervaart Hosp, Dept Pathol, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Dept Pathol, Med Ctr, NL-1007 MB Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Dept Surg, Med Ctr, NL-1007 MB Amsterdam, Netherlands
关键词
azathioprine; hepatotoxicity; inflammatory bowel disease; liver fibrosis; nodular regenerative hyperplasia; sinusoidal dilatation; steatosis; thiopurine;
D O I
10.1080/00365520701800266
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective. Nodular regenerative hyperplasia (NRH) and sinusoidal dilatation have been described in relation to thiopurine use in patients with inflammatory bowel disease (IBD). However, there is a dearth of data on the prevalence of these histological abnormalities in general. The aim of our study was to describe the prevalence of these histological liver changes in a thiopurine-naive IBD cohort. Material and methods. Liver biopsy specimens were obtained from patients who were treated in a referral center and who underwent gastrointestinal surgery for IBD. Patients were excluded if thiopurines were ever used. The liver specimens were pathohistologically assessed with special attention to NRH. Results. A total of 83, properly stained, liver specimens (Crohn's disease 61%) were evaluated. NRH was observed in 6% compared to sinusoidal dilatation of varying degree in 34% of specimens. An older age at biopsy was correlated with NRH (p = 0.015). Fibrosis and steatosis of varying degrees were detected in 31% and 36% of liver biopsies, respectively. No cases of liver cirrhosis were observed. Conclusions. Pathohistological hepatic abnormalities are common in non-thiopurine using IBD patients. The association between thiopurine use, NRH and sinusoidal dilatation may be weaker than as reported in recent literature, as there is relatively high background prevalence in selected series.
引用
收藏
页码:604 / 608
页数:5
相关论文
共 14 条
  • [1] The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients
    Gilissen, Lennard P. L.
    Tajzai, Rudaba
    Romberg, Marielle
    Pierik, Marieke
    Stronkhorst, Arnold
    Steenhuisen, Karin
    Van Bodegraven, Ad
    Daniels, Alette
    Wong, Dennis
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E102 - E107
  • [2] The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients
    Gilissen, Lennard P. L.
    Tajzai, Rudaba
    Romberg, Marielle
    Pierik, Marieke
    Stronkhorst, Arnold
    Steenhuisen, Karin
    Van Bodegraven, Ad
    Daniels, Alette
    Wong, Dennis
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E102 - E107
  • [3] The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naive Inflammatory Bowel Disease Patients
    Crouwel, Femke
    Bayoumy, Ahmed B.
    Mulder, Chris J. J.
    Peters, Job H. C.
    Boekema, Paul J.
    Derijks, Luc J. J.
    de Boer, Sybrand Y.
    van de Meeberg, Paul C.
    Ahmad, Ishfaq
    Buiter, Hans J. C.
    de Boer, Nanne K.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (09) : 1492 - 1499
  • [4] The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease
    van Asseldonk, Dirk P.
    Jharap, Bindia
    Verheij, Joanne
    den Hartog, Gijsbert
    Westerveld, Dik B.
    Becx, Marco C.
    Russel, Maurice G.
    Engels, Leopold G.
    de Jong, Dirk J.
    Witte, Birgit I.
    Mulder, Chris J.
    van Nieuwkerk, Carin M.
    Bloemena, Elisabeth
    de Boer, Nanne K. H.
    van Bodegraven, Ad A.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (09) : 2112 - 2120
  • [5] Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies
    Barge, Sandrine
    Grando, Veronique
    Nault, Jean-Charles
    Broudin, Chloe
    Beaugrand, Michel
    Ganne-Carrie, Nathalie
    Roulot, Dominique
    Ziol, Marianne
    LIVER INTERNATIONAL, 2016, 36 (07) : 1059 - 1066
  • [6] Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients
    de Boer, N. K. H.
    Zondervan, P. E.
    Gilissen, L. P. L.
    den Hartog, G.
    Westerveld, B. D.
    Derijks, L. J. J.
    Bloemena, E.
    Engels, L. G. J. B.
    van Bodegraven, A. A.
    Mulder, C. J. J.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 (02) : 108 - 113
  • [7] Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece
    Coucoutsi, Constantina
    Emmanouil, George
    Goulielmos, George
    Sfakianaki, Ourania
    Koutroubakis, Ioannis E.
    Kouroumalis, Elias A.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (11) : 1284 - 1289
  • [8] High prevalence of Mycoplasma pneumonia in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls
    Chen, WX
    Li, D
    Paulus, B
    Wilson, I
    Chadwick, VS
    DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (11) : 2529 - 2535
  • [9] High Prevalence of Mycoplasma pneumoniae in Intestinal Mucosal Biopsies from Patients with Inflammatory Bowel Disease and Controls
    Wangxue Chen
    Dong Li
    Barbara Paulus
    Ian Wilson
    Vinton S. Chadwick
    Digestive Diseases and Sciences, 2001, 46 : 2529 - 2535
  • [10] Therapeutic Monitoring of Thiopurine Metabolites: Validation of an HPLC Method and Preliminary Findings from a Small Cohort of Malaysian Patients with Inflammatory Bowel Disease
    Lim, Sheng Zhang
    Ali, Raja Affendi Raja
    Makpol, Suzana
    Chua, Eng Wee
    SAINS MALAYSIANA, 2022, 51 (06): : 1847 - 1859